Summary
Updated Aug 31, 2026
Atabak Mokari is Chief Financial Officer of CORCEPT THERAPEUTICS INC (CORT). 10 SEC Form 4 filings on record going back to 2024, most recently on 3 August 2026. Most recent open-market trade: sold $121K of CORT on 3 August 2026. Lifetime open-market sales: $18.73M.
Recent Transactions
20Every recent SEC Form 4 transaction Atabak Mokari has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Atabak Mokari go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. 35 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Atabak Mokari files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sean Maduck - $21.82M of CORT open-market activity in the last 12 months
- William Guyer - $16.68M of CORT open-market activity in the last 12 months
- Joseph K. Belanoff - $16.61M of CORT open-market activity in the last 12 months
- David L. Mahoney - $13.94M of CORT open-market activity in the last 12 months
- G. Leonard Baker Jr. - $3.31M of CORT open-market activity in the last 12 months
- Kimberly Park - $3.27M of CORT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Atabak Mokari?
Atabak Mokari is a corporate insider, tracked as Chief Financial Officer of CORCEPT THERAPEUTICS INC (CORT). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Atabak Mokari submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Atabak Mokari been buying or selling stock?
Recorded transactions: 0 open-market purchases and 22 open-market sales ($18.73M) across all tracked filings.
Where can I see all of Atabak Mokari's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Atabak Mokari and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial